Literature DB >> 35648709

T-Cell Immunotherapy against Mutant KRAS for Pancreatic Cancer.

Cornelis J M Melief1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35648709     DOI: 10.1056/NEJMe2204283

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

Review 1.  TCR engineered T cells for solid tumor immunotherapy.

Authors:  Yikai Zhang; Zhipeng Liu; Wei Wei; Yangqiu Li
Journal:  Exp Hematol Oncol       Date:  2022-06-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.